Kogene Biotech

Through active R&D and investment, we have newly created and activated genetic diagnostic markets in various fields, thereby expanding and developing the previously barren molecular diagnostic market in Korea. We were the first in Korea to develop and provide diagnostic kits to address new infectious diseases, from the 2009 H1N1 flu, the 2015 MERS, to the 2020 Corona 19.